{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:38:04Z","timestamp":1790213884054,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI170172"],"award-info":[{"award-number":["R01AI170172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"publisher","award":["K01AI138863"],"award-info":[{"award-number":["K01AI138863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The correlation between human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) usage and sexually transmitted infections (STIs) remains equivocal. Limited studies have investigated national STI trends after introducing PrEP. We aimed to examine STI incidence before and after PrEP introduction and explore correlations with PrEP use in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PrEP usage data (2012\u20132022) were obtained from AIDSVu, and STI data (2001\u20132022) from the Centers for Disease Control and Prevention's STI Statistics Archive. We used the coefficient of determination to estimate variance in STI rates explained by PrEP usage. We used cross-correlation to identify lagged correlations and segmented linear regression to examine STI trends by demographics before and after PrEP initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Syphilis rates increased by 0.2\/100 000 people annually before 2012 and by 1.4\/100 000 persons after PrEP introduction. Gonorrhea rates dropped by 2.9\/100 000 people before 2012 but rose by 14\/100 000 afterward. The slope for chlamydia dropped from 20.9 to 6.6. The coefficients of determination for syphilis, gonorrhea, and chlamydia attributable to PrEP usage were 0.98, 0.88, and 0.2, respectively. Lagged correlations were significant for chlamydia, but not for syphilis and gonorrhea. Overall, STI rates were more strongly correlated with PrEP usage among males than females.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found significant changes in the rate of incident STIs from 2012 to 2022 and a high correlation between PrEP usage and reported cases of syphilis and gonorrhea. Given the role of PrEP in comprehensive HIV prevention in the United States, its impact on rates of STI infection should be further studied.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf491","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T11:29:41Z","timestamp":1755343781000},"source":"Crossref","is-referenced-by-count":11,"title":["Trends Analysis of Sexually Transmitted Infections Before and After Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States 2001\u20132022"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-2275","authenticated-orcid":false,"given":"Zailing","family":"Xing","sequence":"first","affiliation":[{"name":"College of Public Health, University of South Florida , Tampa, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1621-2820","authenticated-orcid":false,"given":"Daniel","family":"Escudero","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Vanderbilt University Medical Center , Nashville, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2025092508520092700_ofaf491-B1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/00224499.2021.1936440","article-title":"How has HIV pre-exposure prophylaxis (PrEP) changed sex? A review of research in a new era of bio-behavioral HIV prevention","volume":"58","author":"Grov","year":"2021","journal-title":"J Sex Res"},{"key":"2025092508520092700_ofaf491-B2","author":"Food and Drug Administration"},{"key":"2025092508520092700_ofaf491-B3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"2025092508520092700_ofaf491-B4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025092508520092700_ofaf491-B5","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.amepre.2021.05.027","article-title":"Toward greater pre-exposure prophylaxis equity: increasing provision and uptake for Black and Hispanic\/Latino individuals in the US","volume":"61","author":"Bonacci","year":"2021","journal-title":"Am J Prev Med"},{"key":"2025092508520092700_ofaf491-B6","doi-asserted-by":"crossref","first-page":"e25883","DOI":"10.1002\/jia2.25883","article-title":"Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data","volume":"25","author":"Sun","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"2025092508520092700_ofaf491-B7","doi-asserted-by":"crossref","first-page":"e2030806","DOI":"10.1001\/jamanetworkopen.2020.30806","article-title":"Comparison of trends in rates of sexually transmitted infections before vs after initiation of HIV preexposure prophylaxis among men who have sex with men","volume":"3","author":"McManus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025092508520092700_ofaf491-B8","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/jama.2019.2947","article-title":"Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection","volume":"321","author":"Traeger","year":"2019","journal-title":"JAMA"},{"key":"2025092508520092700_ofaf491-B9","author":"Centers for Disease Control and Prevention"},{"key":"2025092508520092700_ofaf491-B10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s10461-020-03110-x","article-title":"Reviewing PrEP's effect on STI incidence among men who have sex with men\u2014balancing increased STI screening and potential behavioral sexual risk compensation","volume":"25","author":"Kumar","year":"2021","journal-title":"AIDS Behav"},{"key":"2025092508520092700_ofaf491-B11","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1016\/S2352-3018(19)30333-9","article-title":"Risk compensation and STI incidence in PrEP programmes: latest evidence and research gaps","volume":"7","author":"Quaife","year":"2020","journal-title":"Lancet HIV"},{"key":"2025092508520092700_ofaf491-B12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/sextrans-2017-053288","article-title":"Social networks as drivers of syphilis and HIV infection among young men who have sex with men","volume":"94","author":"Fujimoto","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2025092508520092700_ofaf491-B13","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/cid\/ciy1141","article-title":"Incidence and correlates of sexually transmitted infections among black men who have sex with men participating in the HIV prevention trials network 073 preexposure prophylaxis study","volume":"69","author":"Hightow-Weidman","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025092508520092700_ofaf491-B14","first-page":"588","article-title":"Predictors and frequency of STIs among MSM on PrEP in Kiambu County, Kenya","volume":"36","author":"Ombati","year":"2024","journal-title":"Afr J Health Sci"},{"key":"2025092508520092700_ofaf491-B15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciy182","article-title":"Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis","volume":"67","author":"Traeger","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025092508520092700_ofaf491-B16","doi-asserted-by":"crossref","first-page":"e1004328","DOI":"10.1371\/journal.pmed.1004328","article-title":"Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort","volume":"21","author":"van den Elshout","year":"2024","journal-title":"PLoS Med"},{"key":"2025092508520092700_ofaf491-B17","doi-asserted-by":"crossref","first-page":"2300451","DOI":"10.2807\/1560-7917.ES.2024.29.13.2300451","article-title":"Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022","volume":"29","author":"von Schreeb","year":"2024","journal-title":"Euro Surveill"},{"key":"2025092508520092700_ofaf491-B18","doi-asserted-by":"crossref","first-page":"15579883211018917","DOI":"10.1177\/15579883211018917","article-title":"Incidence of sexually transmitted infections after initiating HIV pre-exposure prophylaxis among MSM in southern Denmark","volume":"15","author":"Azarnoosh","year":"2021","journal-title":"Am J Mens Health"},{"key":"2025092508520092700_ofaf491-B19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025092508520092700_ofaf491-B20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"key":"2025092508520092700_ofaf491-B21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2\u00d72 factorial design","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025092508520092700_ofaf491-B22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","article-title":"Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study","volume":"42","author":"Bolan","year":"2015","journal-title":"Sex Transm Dis"},{"key":"2025092508520092700_ofaf491-B23","year":"2024"},{"key":"2025092508520092700_ofaf491-B24"},{"key":"2025092508520092700_ofaf491-B25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.annepidem.2020.01.004","article-title":"Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the US ending the HIV epidemic jurisdictions","volume":"44","author":"Sullivan","year":"2020","journal-title":"Ann Epidemiol"},{"key":"2025092508520092700_ofaf491-B26","first-page":"100738","article-title":"Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis","volume":"33","author":"Sullivan","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"2025092508520092700_ofaf491-B27"},{"key":"2025092508520092700_ofaf491-B28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1197\/jamia.M2178","article-title":"Finding leading indicators for disease outbreaks: filtering, cross-correlation, and caveats","volume":"14","author":"Bloom","year":"2007","journal-title":"J Am Med Inform Assoc"},{"key":"2025092508520092700_ofaf491-B29","doi-asserted-by":"crossref","first-page":"e0268670","DOI":"10.1371\/journal.pone.0268670","article-title":"High syphilis prevalence and incidence in people living with HIV and pre-exposure prophylaxis users: a retrospective review in the French Dat\u2019AIDS cohort","volume":"17","author":"Lemmet","year":"2022","journal-title":"PLoS One"},{"key":"2025092508520092700_ofaf491-B30","first-page":"101175","article-title":"Syphilis testing, incidence, and reinfection among gay and bisexual men in Australia over a decade spanning HIV PrEP implementation: an analysis of surveillance data from 2012 to 2022","volume":"51","author":"Traeger","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2025092508520092700_ofaf491-B31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10461-018-2252-9","article-title":"Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting","volume":"23","author":"Monta\u00f1o","year":"2019","journal-title":"AIDS Behav"},{"key":"2025092508520092700_ofaf491-B32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1370\/afm.3152","article-title":"Self-reported PrEP use and risk of bacterial STIs among Ontarian men who are gay or bisexual or have sex with men","volume":"22","author":"Tran","year":"2024","journal-title":"Ann Fam Med"},{"key":"2025092508520092700_ofaf491-B33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/OLQ.0000000000001600","article-title":"Rates of appropriate treatment and follow-up testing after a gonorrhea and\/or chlamydia infection in an urban network of federally qualified health center systems","volume":"49","author":"McWhirter","year":"2022","journal-title":"Sex Transm Dis"},{"key":"2025092508520092700_ofaf491-B34","first-page":"1097","article-title":"Multiple imputation of race and Hispanic ethnicity in national surveillance data for chlamydia, gonorrhea, and syphilis","volume":"10","author":"Pondo","year":"2024","journal-title":"Sex Transm Dis"},{"key":"2025092508520092700_ofaf491-B35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/OLQ.0000000000001709","article-title":"Anal and oral sex behaviors among young black men who have vaginal sex: evidence of the need for extragenital testing for chlamydia and gonorrhea","volume":"49","author":"Ratnayake","year":"2022","journal-title":"Sex Transm Dis"},{"key":"2025092508520092700_ofaf491-B36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12879-022-07171-2","article-title":"Controversies and evidence on chlamydia testing and treatment in asymptomatic women and men who have sex with men: a narrative review","volume":"22","author":"Dukers-Muijrers","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025092508520092700_ofaf491-B37","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s10461-018-2300-5","article-title":"The context of sexual risk behaviour among men who have sex with men seeking PrEP, and the impact of PrEP on sexual behaviour","volume":"23","author":"Gafos","year":"2019","journal-title":"AIDS Behav"},{"key":"2025092508520092700_ofaf491-B38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0956462419886228","article-title":"Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinic","volume":"31","author":"Gravett","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2025092508520092700_ofaf491-B39","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s10461-020-02840-2","article-title":"Overlapping transmission networks of early syphilis and\/or newly HIV diagnosed gay, bisexual and other men who have sex with men (MSM): opportunities for optimizing public health interventions","volume":"24","author":"Jennings","year":"2020","journal-title":"AIDS Behav"},{"key":"2025092508520092700_ofaf491-B40","doi-asserted-by":"crossref","first-page":"1886455","DOI":"10.1080\/16549716.2021.1886455","article-title":"Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts","volume":"14","author":"Shamu","year":"2021","journal-title":"Glob Health Action"},{"key":"2025092508520092700_ofaf491-B41","doi-asserted-by":"crossref","first-page":"992176","DOI":"10.3389\/frph.2022.992176","article-title":"Role of the human vaginal microbiota in the regulation of inflammation and sexually transmitted infection acquisition: contribution of the non-human primate model to a better understanding?","volume":"4","author":"Adapen","year":"2022","journal-title":"Front Reprod Health"},{"key":"2025092508520092700_ofaf491-B42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/sextrans-2017-053377","article-title":"Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California","volume":"94","author":"Beymer","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2025092508520092700_ofaf491-B43","first-page":"1","article-title":"Pre-exposure prophylaxis (PrEP) for HIV infection and new sexually transmitted infections: a win-win opportunity?","volume":"3","author":"Aubin","year":"2021","journal-title":"J AIDS HIV Treat"},{"key":"2025092508520092700_ofaf491-B44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09540121.2021.1957762","article-title":"Shades of risk\u201d: understanding current PrEP users\u2019 sexually transmitted infection perceptions","volume":"34","author":"Klasko-Foster","year":"2022","journal-title":"AIDS Care"},{"key":"2025092508520092700_ofaf491-B45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/apc.2021.0219","article-title":"Trends in sexual behavior and sexually transmitted infections after initiating human immunodeficiency virus pre-exposure prophylaxis in men who have sex with men from Amsterdam, The Netherlands: a longitudinal exposure-matched study","volume":"36","author":"Coyer","year":"2022","journal-title":"AIDS Patient Care STDS"},{"key":"2025092508520092700_ofaf491-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6805a1","article-title":"Recommendations for providing quality sexually transmitted diseases clinical services, 2020","volume":"68","author":"Barrow","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2025092508520092700_ofaf491-B47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jama.2021.23487","article-title":"Diagnosis and treatment of sexually transmitted infections: a review","volume":"327","author":"Tuddenham","year":"2022","journal-title":"JAMA"},{"key":"2025092508520092700_ofaf491-B48","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1136\/sextrans-2016-053073","article-title":"Advancing point of care diagnostics for the control and prevention of STIs: the way forward","volume":"93","author":"Toskin","year":"2017","journal-title":"Sex Transm Infect"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf491\/64076537\/ofaf491.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/9\/ofaf491\/64076537\/ofaf491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/9\/ofaf491\/64076537\/ofaf491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:52:15Z","timestamp":1758804735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf491\/8237291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf491","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,18]]},"article-number":"ofaf491"}}